Health Care: Drugs

Redhill Biopharma Ltd (RDHL: NASDAQ)

$14.47 0.7 | 5.08%
03/30/15 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 13.77
52 Week High 21.00
52 Week Low 6.89
Avg. Daily Vol. (Mil) 0.05
Beta (3 year) -0.41
Share Related Items
Mkt Cap (Mil) 121.02
Shares Out (Mil) 8.79
Float (Mil) 0.00
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 13.30
Current Ratio 15.10
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 17.25
Price/Book 4.84
Price/Cash Flow -11.30
Per Share Data
Earnings -1.24
Sales 0.80
Book Value 2.85
Cash Flow -1.22
Business Summary
Redhill Biopharma Ltd is a biopharmaceutical company. It develops & acquires late clinical-stage, proprietary drugs for the treatment of inflammatory and gastrointestinal diseases, including gastrointestinal cancers.
General Information
21 Ha'arba'a Street
Tel Aviv, 64739
Industry : Drugs
Sector: Health Care
Employees: 10
CEO: Mr. Dror Ben-Asher
Short Interest
Current Month (Mil) 0.00
Previous Month (Mil) 0.02
Short Interest Ratio (Days) 0.20
Management Effectiveness
Return on Equity n.a.
Return on Assets -37.10
Return on Investments -42.80
Gross Margin 85.40
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with RDHL

  • Portfolio NameUser Type

Latest RDHL Headlines from TheStreet

More Financial News for RDHL

Press Releases for RDHL

See All Press Releases

Partner Headlines for RDHL

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter